|
|
| ¾.Ã.ºÂÒàʾµÔ´ãËéâ·É ¾.È. 2522 ÈÙ¹ÂìÇԷºÃÔ¡Òà | 4 |  | 2.92 |
| ˹ѧÊ×ÍÃÒª¡Òà ÀÒÉÒÍѧ¡ÄÉ | 3 | | 2.19 |
| º·¤Ñ´ÂèÍ»ÃÐÊÔ·¸Ô¼Å¢Í§¡ÒùǴÈÃÕÉÐáÅÐµé¹¤Í | 3 | | 2.19 |
| ¢Ñ鹵͹ ¾Ô¨ÒÃ³Ò ¼ÅÔµÀѳ±ì ÍÒËÒà | 3 | | 2.19 |
| ¾.Ã.º. ÂÒàʾµÔ´ãËéâ·É ¾.È. 2522 ÁÒµÃÒ 65 | 3 | | 2.19 |
| ÇԨѠÂÒ¼§ ÂÒÅÙ¡¡Å͹ º·¤Ñ´ÂèÍ | 3 | | 2.19 |
| ÃÑ¡ÉÒâä¤ÇÒÁ´Ñ¹ÊÙ§ | 2 | | 1.46 |
| §Ò¹ãËé¤Ó»ÃÖ¡ÉÒ´éÒ¹ÂÒ | 2 | | 1.46 |
| ¼ÅÔµÀѳ±ìÍÒËÒ÷ÕèäÁè¶Ù¡ºÑ§¤ÑºãËéáÊ´§©ÅÒ¡âÀª¹Ò¡Òà | 2 | | 1.46 |
| µÔ´µèÍ ÍÂ. | 2 | | 1.46 |
| ¡ÒõÃǨʶҹ·Õè¼ÅÔµµÒÁËÅѡࡳ±ìgmp ¹éÓºÃÔâÀ¤ | 2 | | 1.46 |
| ÂÒá¼¹âºÃÒ³ ¤×Í | 2 | | 1.46 |
| ˹èÍäÁéÍÑ´»Ôêº | 2 | | 1.46 |
| drug supply | 2 | | 1.46 |
| abc analysis | 2 | | 1.46 |
| ¢Ñ鹵͹¡ÒüÅÔµ¹Á¡Ãлèͧ | 2 | | 1.46 |
| ¡ÒþѲ¹ÒÇÔ¸Õâ¤ÃÁÒâ·¡ÃҿբͧàËÅÇÊÁÃö¹ÐÊÙ§ÊÓËÃѺÇÔà¤ÃÒÐËì»ÃÔÁÒ³ÍÒÃìºÙµÔ¹ã¹¤ÃÕÁ | 2 | | 1.46 |
| ¢éÍÁÙÅ¢Öé¹·ÐàºÕ¹ÍÂ. | 2 | | 1.46 |
| enalaprill | 2 | | 1.46 |
| ºÃÔºÒÅàÀÊѪ¡ÃÃÁ ¼Ùé»èÇÂâä¤ÇÒÁ´Ñ¹âÅËÔµÊÙ§ þ.»ÑµµÒ¹Õ | 2 | | 1.46 |
| ÁÒµÃÒ°Ò¹ ÍÒËÒÃàÊÃÔÁ | 2 | | 1.46 |
| àÍ¡ÊÒûÃСͺ¡ÒûÃЪØÁ â¦É³Òà¤Ã×èͧ´×èÁ | 2 | | 1.46 |
| àµÕ§¹Ç´ä¿¿éÒ | 2 | | 1.46 |
| chloramphenicol 㹡Øé§ | 2 | | 1.46 |
| ˹ѧÊ×Íà¤Ã×èͧÊÓÍÒ§ÊÓËÃѺ¼ÔÇ˹ѧ hydroquinone | 2 | | 1.46 |
| drug counselling | 2 | | 1.46 |
| ·È¾Å ÇÔ·Ôµ¡¾Ñ·¸ì | 2 | | 1.46 |
| àÃ×èͧÃéͧàÃÕ¹¡ÃзÃǧÊÒ¸ÒóÊØ¢ | 1 | | 0.73 |
| ÃÒª×èÍà¤Ã×èͧÊÓÍÒ§·ÕèÁÕÊÒÃÍѹµÃÒÂËéÒÁãªé | 1 | | 0.73 |
| ¡®ËÁÒ ¡ÅÙµÒä¸â͹ | 1 | | 0.73 |
| à¾Å§ÎÔµ | 1 | | 0.73 |
| ¡ÒÃãËé¤Ó»ÃÖ¡ÉÒ´éÒ¹ÂÒ | 1 | | 0.73 |
| ¾ÃÐäµÃ»Ô®¡©ºÑº»ÃЪҪ¹ ÇèÒ´éǾÃÐÊٵà | 1 | | 0.73 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢©ºÑº·Õè 104 | 1 | | 0.73 |
| dexsamethasone | 1 | | 0.73 |
| à¤Ã×èͧ¾ÒÊà¨ÍÃìäÃÊ좹ҴàÅç¡ | 1 | | 0.73 |
| äÁâ¤Ã«Í¿µì àÍʤÔÇáÍÅ à«ÔÃì¿àÇÍÃì 2000 | 1 | | 0.73 |
| à¤Ã×èͧÁ×Íá¾·Âì | 1 | | 0.73 |
| ¢Ñ鹵͹¡ÒüÅÔµ¹Á | 1 | | 0.73 |
| ÊÕ¼ÊÁÍÒËÒà ÍÂ. | 1 | | 0.73 |
| ÍѹµÃÒÂâ´ÁÔ¤ØÁ | 1 | | 0.73 |
| ÇÔ¸Õà¡çºµÑÇÍÂèÒ§ÊÒÃà¤ÁÕ nmam | 1 | | 0.73 |
| á¹Ç·Ò§ã¹¡ÒäǺ¤ØÁÊØÃÒẺºÙóҡÒà | 1 | | 0.73 |
| ¤ÅÍáÃÁ ÊѵÇì | 1 | | 0.73 |
| ÊÒÃйèÒÃÙéà¡ÕèÂǡѺà¤Ã×èͧÊÓÍÒ§ | 1 | | 0.73 |
| www.fda.moph.go.th | 1 | | 0.73 |
| á͹â¸ä«ÂÒ¹Ô¹Êì | 1 | | 0.73 |
| ÂÒ©Õ´à¾ÔèÁ¡ÅéÒÁà¹×éÍ | 1 | | 0.73 |
| ¾Ãº.ÂÒ 2518 ©ºÑºá¡éä¢ 2 | 1 | | 0.73 |
| ˹èÇ ÍÒËÒà âÁºÒ | 1 | | 0.73 |
| ¢éÍÃéͧàÃÕ¹¡ÃзÃǧÊÒ¸ÒóÊØ¢ | 1 | | 0.73 |
| à͹ä«ÁìáŤàµÊ | 1 | | 0.73 |
| ãªéÂÒËÂÍ´µÒËÁ´ÍÒÂØ | 1 | | 0.73 |
| âç§Ò¹¼ÅÔµ¹éÓËÇÒ¹ | 1 | | 0.73 |
| ·ÄɮպÃÃÉÑ·¢éÒÁªÒµÔ | 1 | | 0.73 |
| ÍÂ. »ÃСÒȪ×èÍà¤Ã×èͧÊÓÍÒ§ÁÕÊÒÃÍѹµÃÒ ãªéáÅéÇ˹éҾѧ¶ÒÇà | 1 | | 0.73 |
| ÍÂ. àÊÃÔÁÍÒËÒà ¼ÅÔµÀѳ±ì | 1 | | 0.73 |
| ¢éͺѧ¤ÑºÇѵ¶Øà¨×Í»¹ÍÒËÒà | 1 | | 0.73 |
| ÂÒ and ÇѹÊÔé¹ÍÒÂØ | 1 | | 0.73 |
| à¨Å·Ô¹·ì | 1 | | 0.73 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions